Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells

od Proietti, Cecilia, Salatino, Mariana, Rosemblit, Cinthia, Carnevale, Romina, Pecci, Adalí, Kornblihtt, Alberto R., Molinolo, Alfredo A., Frahm, Isabel, Charreau, Eduardo H., Schillaci, Roxana, Elizalde, Patricia V.
Izdano 2005

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer

od Schillaci, Roxana, Guzmán, Pablo, Cayrol, Florencia, Beguelin, Wendy, Díaz Flaqué, María C, Proietti, Cecilia J, Pineda, Viviana, Palazzi, Jorge, Frahm, Isabel, Charreau, Eduardo H, Maronna, Esteban, Roa, Juan C, Elizalde, Patricia V
Izdano 2012

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

od Mercogliano, María F., Inurrigarro, Gloria, De Martino, Mara, Venturutti, Leandro, Rivas, Martín A., Cordo-Russo, Rosalía, Proietti, Cecilia J., Fernández, Elmer A., Frahm, Isabel, Barchuk, Sabrina, Allemand, Daniel H., Figurelli, Silvina, Deza, Ernesto Gil, Ares, Sandra, Gercovich, Felipe G., Cortese, Eduardo, Amasino, Matías, Guzmán, Pablo, Roa, Juan C., Elizalde, Patricia V., Schillaci, Roxana
izdano v BMC Cancer (2017)

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

od Weinberg, Ruth S, Grecco, Marcelo O, Ferro, Gimena S, Seigelshifer, Debora J, Perroni, Nancy V, Terrier, Francisco J, Sánchez-Luceros, Analía, Maronna, Esteban, Sánchez-Marull, Ricardo, Frahm, Isabel, Guthmann, Marcelo D, Di Leo, Daniela, Spitzer, Eduardo, Ciccia, Graciela N, Garona, Juan, Pifano, Marina, Torbidoni, Ana V, Gomez, Daniel E, Ripoll, Giselle V, Gomez, Roberto E, Demarco, Ignacio A, Alonso, Daniel F
izdano v Springerplus (2015)